Rapid Growth NeuroStim TMS is expanding across multiple states with 16 centers and a recent office expansion in Gilbert, AZ, presenting a scalable opportunity to cross-sell existing services to new regional markets and increase patient reach.

One-Day TMS The launch of One-Day TMS accelerates treatment timelines, enabling quicker patient throughput and higher capacity utilization, which can be leveraged to upsell to referring clinicians seeking efficient, evidence-based mood disorder therapies.

Clinical Partnerships Active collaboration with Magstim Group and participation in neuroscience congresses indicate a gateway to co-marketing, training programs, and joint events that can expand referral networks and technology adoption.

Revenue Growth With a revenue range of $1M–$10M and a sizable service footprint, there is room to optimize payer mix, expand high-margin services, and pursue enterprise-level contracts with health systems and insurers.

Patient Footprint Having treated over 300,000 patients and expanding to new markets signals strong demand for TMS therapies; sales efforts can focus on expanding clinician referrals, EMR integrations, and patient outcomes data to drive referrals.